Market closed
Fortrea Holdings/$FTRE
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Fortrea Holdings
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Ticker
$FTRE
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
15,500
Website
Fortrea Holdings Metrics
BasicAdvanced
$1.9B
Market cap
-
P/E ratio
-$3.36
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$1.9B
52-week high
$41.02
52-week low
$16.53
Average daily volume
1.4M
Financial strength
Current ratio
1.177
Quick ratio
0.998
Long term debt to equity
78.764
Total debt to equity
79.736
Interest coverage (TTM)
-0.49%
Management effectiveness
Return on assets (TTM)
-1.04%
Return on equity (TTM)
-13.59%
Valuation
Price to revenue (TTM)
0.634
Price to book
1.25
Price to tangible book (TTM)
-2.01
Price to free cash flow (TTM)
8.39
Growth
Revenue change (TTM)
2.80%
Earnings per share change (TTM)
-581.17%
What the Analysts think about Fortrea Holdings
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Fortrea Holdings stock.
Fortrea Holdings Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Fortrea Holdings Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Fortrea Holdings News
AllArticlesVideos
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
Accesswire·13 hours ago
Fortrea to Present at the Citi Global Healthcare Conference
GlobeNewsWire·2 weeks ago
Fortrea to Present at the Evercore HealthCONx Conference
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Fortrea Holdings stock?
Fortrea Holdings (FTRE) has a market cap of $1.9B as of December 12, 2024.
What is the P/E ratio for Fortrea Holdings stock?
The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of December 12, 2024.
Does Fortrea Holdings stock pay dividends?
No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of December 12, 2024.
When is the next Fortrea Holdings dividend payment date?
Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.
What is the beta indicator for Fortrea Holdings?
Fortrea Holdings (FTRE) does not currently have a Beta indicator.